LIFECORE BIOMEDICAL, INC. Related Party Transaction, Amounts of Transaction
LIFECORE BIOMEDICAL, INC. (LFCR) reported Related Party Transaction, Amounts of Transaction of $1.70 million for the 3-month period ending 2012-11-25, per its 10-Q filed 2013-01-04.
Discontinued › Notes › Related Party Transactions
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2013-01-04
- LIFECORE BIOMEDICAL, INC. related party transaction, amounts of transaction for the quarter ending 2012-11-25 was $1.70M, a 6.25% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. related party transaction, amounts of transaction for the quarter ending 2012-08-26 was $2.20M, a 69.23% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. related party transaction, amounts of transaction for the quarter ending 2011-11-27 was $1.60M.
- LIFECORE BIOMEDICAL, INC. related party transaction, amounts of transaction for the quarter ending 2011-08-28 was $1.30M.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month |
|---|---|---|
| 2012-11-25 | $1.70M 10-Q · filed 2013-01-04 | $3.80M 10-Q · filed 2013-01-04 |
| 2012-08-26 | $2.20M 10-Q/A · filed 2013-01-02 | |
| 2011-11-27 | $1.60M 10-Q · filed 2013-01-04 | $2.90M 10-Q · filed 2013-01-04 |
| 2011-08-28 | $1.30M 10-Q/A · filed 2013-01-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |